Edition:
United Kingdom

Mirati Therapeutics Inc (MRTX.OQ)

MRTX.OQ on NASDAQ Stock Exchange Global Select Market

64.92USD
18 Jan 2019
Change (% chg)

-- (--)
Prev Close
$64.92
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
244,387
52-wk High
$67.03
52-wk Low
$24.65

Chart for

About

Mirati Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of targeted oncology products. The Company's clinical pipeline consists of three product candidates: MGCD265, MGCD516 and mocetinostat. MGCD265 and MGCD516 are orally-bioavailable, spectrum-selective kinase... (more)

Overall

Beta: 1.68
Market Cap(Mil.): $362.06
Shares Outstanding(Mil.): 24.97
Dividend: --
Yield (%): --

Financials

  MRTX.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -3.43 -- --
ROI: -91.06 8.99 14.48
ROE: -91.23 10.13 15.99

Earnings vs. Estimates